Gloria Mayela Aguirre-García

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 170 citations · Full text

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis

Eduardo Pérez-Alba, Laura Nuzzolo-Shihadeh, Gloria Mayela Aguirre-García et al. · Journal of Microbiology Immunology and Infection · 2021 · 39 citations · Full text

Frequency of facial touching in patients with suspected COVID-19 during their time in the waiting room

Eduardo Pérez-Alba, Laura Nuzzolo-Shihadeh, Alejandro Fonseca-Ruiz et al. · Infection Control and Hospital Epidemiology · 2020 · 13 citations · Full text